Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified antisense oligomers for exon inclusion in spinal muscular atrophy

Modified antisense oligomers for exon inclusion in spinal muscular atrophy

US Patent 12121532 · Granted Oct 22, 2024

Estimated economic value: $192,614,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide oligonucleotide conjugates2025
Exon skipping oligomer conjugates for muscular dystrophy2025
Exon skipping oligomer conjugates for muscular dystrophy2025
Chimeric peptides for antisense delivery2025
Gene therapy for neurodegenerative disorders2025
Peptide oligonucleotide conjugates2025
Trimeric peptides for antisense delivery2024
Cell-penetrating peptides for antisense delivery2024
Gene therapy for neurodegenerative disorders2024
Gene therapy for neurometabolic disorders2024
Gene therapy for neurodegenerative disorders2024
Peptide oligonucleotide conjugates2023